Loading...
XSHE000705
Market cap354mUSD
Jan 06, Last price  
7.77CNY
1D
1.83%
1Q
-10.28%
Jan 2017
-40.55%
Name

Zhejiang Zhenyuan Share Co Ltd

Chart & Performance

D1W1MN
XSHE:000705 chart
P/E
31.80
P/S
0.63
EPS
0.24
Div Yield, %
0.77%
Shrs. gr., 5y
-0.20%
Rev. gr., 5y
7.52%
Revenues
4.11b
-0.94%
716,732,831880,572,204908,433,631954,582,9101,112,773,6041,276,037,7011,503,278,7151,719,497,2441,812,211,1152,018,147,6452,081,233,1402,163,505,5482,440,003,8922,577,916,0462,858,058,6263,243,149,4113,439,840,4403,612,045,2554,145,479,3054,106,371,595
Net income
82m
+4.79%
7,219,9165,295,7567,763,1597,729,82412,244,51817,791,33021,072,40531,536,13347,672,70264,438,12439,078,85836,225,61645,275,57761,082,49070,884,105211,570,67889,392,93477,295,07077,909,26581,642,566
CFO
91m
10,832,67428,940,50748,743,35248,384,36331,792,46026,217,24149,076,3800126,488,86217,390,49781,407,56756,744,630115,993,13351,721,83225,488,980118,359,124154,814,64075,165,175090,819,928
Dividend
Jun 07, 20240.06 CNY/sh
Earnings
Apr 11, 2025

Profile

Zhejiang Zhenyuan Share Co., Ltd. operates as a pharmaceutical company in China and internationally. It offers Chinese patent medicines, Chinese medicinal materials, Chinese herbal medicines, chemical preparations, chemical raw materials, biochemical drugs, anesthetics, psychotropic drugs, medical devices, chemical reagents, etc. The company offers its products under the Zhenyuan and Zhenyuantang brands. It serves pharmaceutical commerce and health service industries. The company was founded in 1752 and is based in Shaoxing, China.
URL
http://www.zjzy.com/
IPO date
Apr 10, 1997
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
4,106,372
-0.94%
4,145,479
14.77%
Cost of revenue
3,998,302
3,906,533
Unusual Expense (Income)
NOPBT
108,069
238,946
NOPBT Margin
2.63%
5.76%
Operating Taxes
25,236
20,644
Tax Rate
23.35%
8.64%
NOPAT
82,833
218,302
Net income
81,643
4.79%
77,909
0.79%
Dividends
(20,047)
(20,505)
Dividend yield
0.55%
0.77%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
28,083
Long-term debt
109,922
106,162
Deferred revenue
75,241
79,139
Other long-term liabilities
1
Net debt
(532,694)
(703,427)
Cash flow
Cash from operating activities
90,820
CAPEX
(194,056)
Cash from investing activities
1,139
109,310
Cash from financing activities
(66,227)
FCF
(76,380)
45,591
Balance
Cash
458,889
453,484
Long term investments
183,727
384,188
Excess cash
437,297
630,398
Stockholders' equity
1,294,424
1,415,597
Invested Capital
1,691,690
1,445,377
ROIC
5.28%
15.43%
ROCE
5.00%
11.21%
EV
Common stock shares outstanding
334,123
334,123
Price
10.89
37.33%
7.93
-10.70%
Market cap
3,638,603
37.33%
2,649,598
-10.70%
EV
3,128,763
1,969,628
EBITDA
208,708
331,221
EV/EBITDA
14.99
5.95
Interest
3,331
4,100
Interest/NOPBT
3.08%
1.72%